✦ LIBER ✦

Hyperfractionated, accelerated chemoradiation with concurrent mitomycin-C and cisplatin in locally advanced head and neck cancer, a phase I/II study

✍ Scribed by Thomas Hehr; Johannes Classen; Stefan Welz; Ute Ganswindt; Heike Scheithauer; Asen Koitschev; Michael Bamberg; Wilfried Budach

Book ID: 118496692
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 80
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2006.05.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Phase I/II docetaxel plus concurrent hyp

Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)

✍ Agustí Barnadas; Ricard Mesía; Margarita Majem; Ramón Galiana; Antonio López-Pou 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 182 KB

Phase I study of concomitant chemoradiat

Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer

✍ A. Planting; M. de Jonge; P. Jansen; J. Kerrebijn; M. Smith; J.Verweij 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 242 KB

A phase I study of dose-escalated chemor

A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer

✍ Teresa Guerrero Urbano; Catharine H. Clark; Vibeke N. Hansen; Elizabeth J. Adams 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Hyperfractionated, accelerated radiother

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: Quality of life in a prospective phase I/II trial

✍ Jolie Ringash; Gina Lockwood; Brian O’Sullivan; Padraig Warde; Andrew Bayley; Be 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which